CO167 Evaluating Risk of Progression with Selumetinib in Pediatric Patients with Neurofibromatosis Type 1 and Plexiform Neurofibroma: Propensity Score Method (PSM) Analysis of the Sprint Trial Vs a Natural History (NH) Control Arm

Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.2303
https://www.valueinhealthjournal.com/article/S1098-3015(23)02403-8/fulltext
Title : CO167 Evaluating Risk of Progression with Selumetinib in Pediatric Patients with Neurofibromatosis Type 1 and Plexiform Neurofibroma: Propensity Score Method (PSM) Analysis of the Sprint Trial Vs a Natural History (NH) Control Arm
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)02403-8&doi=10.1016/j.jval.2023.03.2303
First page :
Section Title :
Open access? : No
Section Order : 11630
Categories :
Tags :
Regions :
ViH Article Tags :